首页 | 本学科首页   官方微博 | 高级检索  
检索        

腹腔镜胆囊切除术治疗胆囊结石伴慢性胆囊炎患者治疗效果分析
引用本文:罗登,赖习华,刘首记.腹腔镜胆囊切除术治疗胆囊结石伴慢性胆囊炎患者治疗效果分析[J].实用肝脏病杂志,2021,24(2):276-279.
作者姓名:罗登  赖习华  刘首记
作者单位:412008 湖南省株洲市 湖南中医药高等专科学校附属第一医院普外科(罗登,刘首记); 中南大学湘雅医学院附属株洲医院普外科(赖习华)
摘    要:目的 探讨采用腹腔镜胆囊切除术(LC)治疗胆囊结石伴慢性胆囊炎患者的治疗效果及血清胃泌素(GAS)、胃动素(MOT)和血管活性肠肽(VIP)水平的变化。方法 2018年3月~2020年3月我院普外科就诊的70例胆囊结石伴慢性胆囊炎患者,采用随机数字表法将患者分为对照组35例和观察组35例,分别行小切口胆囊切除术或行LC术治疗。采用ELISA法检测血清肿瘤坏死因子-ɑ(TNF-ɑ)、C-反应蛋白(CRP)、白细胞介素-6(IL-6)、GAS、MOT和VIP水平。结果 观察组手术持续时间为(60.6±6.5)min,显著短于对照组【(95.4±7.2)min,P<0.05】,术后住院日为(5.3±1.4)d,显著短于对照组【(7.7±2.5)d,P<0.05】,术中出血量为(42.3±12.4)mL,显著少于对照组【(124.5±21.7)mL,P<0.05】;术后3 d,观察组血清谷氨酰转肽酶(GGT)水平为(41.4±9.3)U/L,显著低于对照组【(65.1±10.5)U/L,P<0.05】,血清天冬氨酸氨基转移酶(AST)水平为(45.3±17.5)U/L,显著低于对照组【(71.2±19.7)U/L,P<0.05】,血清丙氨酸氨基转移酶(ALT)水平为(28.0±20.5)U/L,显著低于对照组【(59.5±22.8)U/L,P<0.05】;血清CRP水平为(28.4±8.3)ng/L,显著低于对照组【(35.7±8.7)ng/L,P<0.05】,血清IL-6水平为(42.4±5.3)ng/L,显著低于对照组【(47.7±6.7)ng/L,P<0.05】,血清TNF-ɑ水平为(1.9±0.5)μg/L,显著低于对照组【(4.7±0.9)μg/L,P<0.05】;血清GAS水平为(129.5±12.4)ng/L,显著高于对照组【(112.7±10.6)ng/L,P<0.05】,血清MOT水平为(242.4±38.7)ng/L,显著高于对照组【(197.6±42.4)ng/L,P<0.05】,和血清VIP水平为(18.2±3.7)pg/mL,显著低于对照组【(22.8±5.3)pg/mL,P<0.05】;术后,观察组并发症发生率为8.6%,显著低于对照组(20.0%,P<0.05)。结论 采用LC治疗胆囊结石伴慢性胆囊炎患者可明显改善手术相关指标,降低血清VIP水平,升高血清GAS和MOT水平,改善胃肠功能,手术安全,疗效肯定。

关 键 词:胆囊结石  慢性胆囊炎  腹腔镜胆囊切除术  疗效  胃泌素  胃动素  血管活性肠肽  
收稿时间:2020-06-18

Efficacyof laparoscopic cholecystectomy in the treatment of patients with gallstones and chronic cholecystitis
Luo Deng,Lai Xihua,Liu Shouji.Efficacyof laparoscopic cholecystectomy in the treatment of patients with gallstones and chronic cholecystitis[J].Journal of Clinical Hepatology,2021,24(2):276-279.
Authors:Luo Deng  Lai Xihua  Liu Shouji
Institution:Department of General Surgery,First Affiliated Hospital, Hunan TCM College, Zhuzhou 412008,Hunan Province, China
Abstract:Objective To investigate the efficacy of laparoscopic cholecystectomy(LC)in the treatment of patients with gallstones and chronic cholecystitis.Methods 70 patients with gallstones and chronic cholecystitis were enrolled in our hospital between March 2018 and March 2020,and were randomly divided into control group(n=35)and observation group(n=35).The patients in the control group were treated with open cholecystectomy with small incision,and those in the observation group were treated with LC.Serum gastrin(GAS),vactive intestinal peptide(VIP)and motilin(MOT)levels were detected by ELISA.Results The operationtime in the observation group was(60.6±6.5)min,which was significantly shorter than that in the control group(95.4±7.2)min,P<0.05],the postoperative hospital stay was(5.3±1.4)d,which was significantly shorter than that in the control group(7.7±2.5)d,P<0.05],and the intraoperative blood loss was(42.3±12.4)mL,which was significantly less than that in the control group(124.5±21.7)mL,P<0.05];serum glutamyl transferase(GGT)level in the observation group was(41.4±9.3)U/L,which was significantly lower than in the control group(65.1±10.5)U/L,P<0.05],serum aspartate aminotransferase(AST)level was(45.3±17.5)U/L,which was significantly lower than in the control group(71.2±19.7)U/L,P<0.05],and serum alanine aminotransferase(ALT)level was(28.0±20.5)U/L,which was significantly lower than in the control group(59.5±22.8)U/L,P<0.05];serum C-reactive protein(CRP)level was(28.4±8.3)ng/L,which was significantly lower than in the control group(35.7±8.7)ng/L,P<0.05],serum interleukin-6(IL-6)level was(42.4±5.3)ng/L,which was significantly lower than that in the control group(47.7±6.7)ng/L,P<0.05],serum tumor necrosis factor-ɑ(TNF-ɑ)level was(1.9±0.5)μg/L,which was significantly lower than that in the control group(4.7±0.9)μg/L,P<0.05];serum GAS level was(129.5±12.4)ng/L,which was significantly higher than that in the control group(112.7±10.6)ng/L,P<0.05],serum MOT level was(242.4±38.7)ng/L,which was significantly higher than that in the control group(197.6±42.4)ng/L,P<0.05],and serum VIP level was(18.2±3.7)pg/mL,which was significantly lower than that in the control group(22.8±5.3)pg/mL,P<0.05];after operation,the incidence of complications in the observation group was 8.6%,significantly lower than that in the control group(20.0%,P<0.05).Conclusion The application of laparoscopic cholecystectomy for treatment of patients with gallstones and chronic cholecystitis is efficacious,which might significantly decrease serum VIP level and increase serum GAS and MOT levels,improve gastrointestinal function restoration,and relieve inflammation reaction.
Keywords:Gallstones  Chronic cholecystitis  Laparoscopic cholecystectomy  Efficacy  Gastrin  motilin  Vasoactive intestinal peptide
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《实用肝脏病杂志》浏览原始摘要信息
点击此处可从《实用肝脏病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号